Who invested in DiscGenics

2 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$16Mraised across 2 rounds since 2011, from 2 sources

$1.8MVenture$14MSeries B

Latest round: Series B, $14MSept 2017
Step-upi: 7.6×
Investors: 2

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

201220132014201520162017

$1.8MVenture$14MSeries B

First round: Venture, $1.8M
Biggest round: $14M
Between rounds: 5.9 years

The rounds

Sept 2017
Series B$14M2 new
- Mitsubishi UFJ
- the company's Board of Directors
Reported by FinSMEs
Oct 2011
Venture$1.8M
No investor was named in the report.
Reported by sec.govSEC filing: $1.8M sold, first sale Aug 2010

Founders and team

From DiscGenics's own website and the SEC filings it signed: 7 on the team.

Bob WynalekInterim Chief Executive Officer, Director
Colin Lee NovickDirector
Christopher D. DuntschExecutive Officer, Directori
Greg A. ZiskindExecutive Officeri
J. Flagg FlanaganDirector
Kevin T. FoleyExecutive Officer, Directori
Mike A. MoffatExecutive Officeri

On the board, as filediMark S. Cohen

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Venture2011Series B2017Mitsubishi UFJthe company's Board of Directors

Everyone who backed them

Mitsubishi UFJno record of our own yet1round

the company's Board of Directorsno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list DiscGenics as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.